BMO Capital Markets (:) has been given an average rating of “N/A” by the zero analysts that are covering the stock, MarketBeat reports.
WARNING: “BMO Capital Markets () Receives Consensus Recommendation of “” from Analysts” was posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://transcriptdaily.com/2017/07/24/0-42-earnings-per-share-expected-for-abiomed-inc-nasdaqabmd-this-quarter-updated.html.
About BMO Capital Markets
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
Receive News & Ratings for BMO Capital Markets Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BMO Capital Markets and related companies with MarketBeat.com’s FREE daily email newsletter.